# EDGAR Filing Document

**Accession Number:** 0001419051
**File Stem:** 0001493152-23-003816
**Filing Date:** 2023-2
**Character Count:** 2681
**Document Hash:** 6e9b8688e5a12a88c643877199113777
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-003816.hdr.sgml**: 20230316

**ACCESSION NUMBER**: 0001493152-23-003816

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230207

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
- **CENTRAL INDEX KEY:** 0001419051
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **IRS NUMBER:** 451226465
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 701 WILD ROSE LANE
- **CITY:** ELK CITY
- **STATE:** ID
- **ZIP:** 83525
- **BUSINESS PHONE:** (760) 295-7208

**MAIL ADDRESS:**
- **STREET 1:** 701 WILD ROSE LANE
- **CITY:** ELK CITY
- **STATE:** ID
- **ZIP:** 83525

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Friendly Auto Dealers, Inc.
- **DATE OF NAME CHANGE:** 20071120

---

| | |
|:---|:---|
| ![](formcorresp_01.jpg) | 701 Wild Rose Lane<br> Elk City, ID, 83525<br>4093 Oceanside Blvd. Suite B<br> Oceanside, CA, 92056 |

---

U.S. Securities and Exchange Commission

Division of Corporate Finance

Office of Industrial Applications and Services

100 F Street, N.E.

Washington, D.C. 20549-7561

---

| | |
|:---|:---|
| Re: | **Therapeutic Solutions International, Inc. (TSOI)** |
|  | **Registration Statement on Form S-1A** |
|  | **File No.: 333-268070** |

---

February 7, 2023

Ladies and Gentlemen:

This correspondence is Therapeutic Solutions International, Inc.'s, ("TSOI") response to your comments letter of February 6, 2023 and describes how each of the comments has been addressed in the amended filing of February 7, 2023, S-1A, Amendment Four (4).

<u>Executive Compensation, page 46</u>

<u>Comment 1</u>. *We note your revisions in response to our prior comment 2. Please ensure that Footnotes 1 and 2 of your table consistently apply to the years they reference. For example, it appears that Footnote 1, which is next to Timothy G. Dixon's 2022 salary figure, refers to compensation that was accrued and paid in 2021*.

**Response: The compensation disclosure has been updated as of the recently completed fiscal year ended December 31, 2022 and the Footnotes 1 and 2 now correspond accordingly.**

It would be appreciated if, as soon practicable, you would inform the company and Hugh Kelso at (619) 840-5056, if there are any additional actions required

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| Therapeutic Solutions International, Inc. | Therapeutic Solutions International, Inc. |
| By: | */s/: Timothy G. Dixon* |
|  | Timothy G. Dixon |
|  | Chief Executive Officer |

---